Company intelligence / Profile preview

ALPHAMADE

Ownership: Private
Development stage: Other

Overview

Alphamade was a German pharmaceutical company specializing in the manufacture of patient-specific infusion solutions and formulations. Based in Berlin, the company produced customized medications, including cytostatic agents for chemotherapy and parenteral nutrition solutions tailored to individual patient needs. Alphamade supplied its products to doctors, pharmacists, and hospitals across Germany, ensuring compliance with the German Medicinal Products Act and Good Manufacturing Practice (GMP) guidelines. In 2016, the company was acquired by GHD GesundHeits GmbH Deutschland, and in 2023, its successor entity was formally merged into GHD's compounding operations in Greven.

Therapeutic areas: Metabolic DisordersOncology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

GO! Express & Logistics

Beyond the preview

Go deeper on ALPHAMADE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALPHAMADE.

Explore the full profile